ABLE
-
Salix initiates Target 3 phase 3 study
Salix initiates Target 3 phase 3 study to assess repeat treatment efficacy and safety of Rifaximin 550MG TID in subjects with irritable bowel syndrome with diarrhea
ABLE | 06 April 2012
-
Victoza now available to people with type 2 diabetes in China
Approved by the Chinese State Food and Drug Administration (SFDA) on 15 March 2011.
ABLE | 10 October 2011
-
Watson's rosuvastatin zinc tablets receive tentative FDA approval
Watson Pharmaceuticals Inc announced that its subsidiary, Watson Laboratories Inc, has received tentative approval from the United States Food and Drug Administration (FDA) for its rosuvastatin zinc 5, 10, 20 and 40 mg tablets. Watson's rosuvastatin …
ABLE | 10 August 2011
-
Roche Children's Walk 2011: Raising awareness for vulnerable children
Every year since 2003 Roche employees raise awareness for children in need by walking to collect donations for day-care centres in Malawi and children’s charities in their own countries. Their commitment is supported by Roche, which organises the C…
ABLE | 16 June 2011
-
Diabetes population in urban China shows considerable growth in last decade
In the past decade, the urban diabetes population in China has grown considerably, according to new research by GfK HealthCare’s Roper Global Diabetes Group. The prevalence of diagnosed diabetes has increased by more than 40 percent and the populat…
ABLE | 03 June 2011
-
Smartphones, tablets aid consumerisation of healthcare
Consumer-driven healthcare will gather momentum in 2011 as the public takes more responsibility for its own health, with technology playing a key role, according to Ovum . In the 2011 Trends to Watch: Healthcare Technology report, the independent…
ABLE | 23 February 2011
-
Specialty injectable drugs to top US$90 billion by 2014
Driven by greater patient acceptance and evolving formulation and administration options, the global value of specialty injectable drugs in key market segments will grow to more than US$90 billion over the next four years, according to the estimates …
ABLE | 28 January 2011
-
Easy and reliable transmembrane protein characterization
The Universite de Provence and Universite de la Mediterranee in Marseille, France, have implemented the innovative Wyatt Multi-Angle Light Scattering (MALS) detectors for use in their biological macromolecules joint research unit. The instruments…
ABLE | 30 December 2010
-
Bioresorbable vascular scaffold demonstrates strong results
Abbott announces positive nine-month results from the first 45 patients enrolled in the second stage of the Absorb trial. At nine months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results that remained consistent with the si…
ABLE | 03 October 2010
-
SP Scientific: safe, easy and reliable cryopreservation
The Bio-Cool from SP Scientific is the only controlled rate freezer that does not require expendable liquid nitrogen and the associated pumping, re-filling, and storage challenges posed by a cryogenic liquid. The Bio-Cool plugs into a standard elect…
ABLE | 01 October 2010
